Market Overview

Morning Market Movers

Share:
Related GPRC
Kandi Technologies Says SEC Won't Act On Probe
Morning Market Losers
Related GERN
Oppenheimer Is Excited About These 3 Biotech Stocks
Benzinga's Top #PreMarket Gainers
Next Week In Biotech: Gilead, Celgene Report; PDUFAs For Theravance, The Medicines Co. (Seeking Alpha)

Celldex Therapeutics (NASDAQ: CLDX) surged 25.34% to $6.9190 at 9:54 am. Celldex Therapeutics announced final results from the company's randomized Phase 2b EMERGE study of CDX-011 in patients with glycoprotein NMB (GPNMB)-expressing, advanced, heavily pretreated breast cancer.

Guanwei Recycling (NASDAQ: GPRC) climbed 25.15% to $2.09. Guanwei Recycling's trailing-twelve-month ROE is 33.04%.

Geron (NASDAQ: GERN) surged 24.53% to $1.32. Geron reported positive clinical results from the Phase 2 trial of imetelstat in patients with essential thrombocythemia.

Intermec (NYSE: IN) shares advanced 22.68% to $9.79. Honeywell International (NYSE: HON) announced its plans to buy Intermec for $600 million.

Posted-In: Morning Market MoversNews Intraday Update Markets Movers

 

Related Articles (CLDX + GERN)

Around the Web, We're Loving...